The bank’s AML controls have been under scrutiny for a number of years, but new allegations emerged in May that Chinese crime groups were able to exploit weaknesses to hide funds derived from sales of fentanyl in the US.
The bank said at the time that it expected additional
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day